ESPR FY 2015 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ESPREsperion Therapeutics, Inc.

$512M

FY 2015 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

-$236,000

Operating Income

-$50M

Net Income

-$50M

EPS (Diluted)

$-2.26

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$296M

Total Liabilities

$8M

Stockholders' Equity

$287M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$236,000	$0	—
Operating Income	-$50M	-$36M	-38.1%
Net Income	-$50M	-$36M	-36.9%